The Board of Mochida Pharmaceutical Co., Ltd. has authorized a buyback plan on August 1, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,110 JPY | +1.97% | +2.47% | -4.89% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.89% | 691M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.87% | 248B | |
-0.94% | 219B | |
+11.06% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Mochida Pharmaceutical Co., Ltd. authorizes a Buyback Plan.